medigraphic.com

2021, Number 2

<< Back Next >>

Rev Mex Anest 2021; 44 (2)

Hypersensitivity reaction secondary to the use of neuromuscular blockers

Fuentes-Broqueet RE, Cordero-Escobar I, Pérez-Martínez G, Mora-Díaz I

Language: Spanish
References: 35
Page: 105-109
PDF size: 254.25 Kb.


ABSTRACT

Introduction: Perioperative anaphylaxis is a potentially lethal clinical condition. The most frequent cause is attributed to neuromuscular blockers. Objective: To identify the incidence of anaphylactic reactions secondary to the use of neuromuscular blockers. Material and methods: A descriptive, observational, cross-sectional investigation was conducted to assess the incidence of anaphylactic reactions secondary to the use of neuromuscular blockers. The study was carried out at the "Hermanos Ameijeiras" Hospital, in the period between january 2016 and december 2018. Results: Of the total elective surgical interventions, 3,431 required general anesthesia and the use of neuromuscular blockers. The female sex predominated with 75%, the age group of 60 years and over with 68 patients (32.7%), ASA II physical condition, 98 patients (41.1%). The average BMI was 22.7 ± 1.14. The mean surgical time was 190 ± 42.5 min. Of all the drugs the most used was atracurium in 90 patients (43.3%), followed by vecuronium 79 (38.0%) and rocuronium 39 (18.8%). The number of adverse events was low. Only four were found, two with atracurium (50%), one with rocuronium and one with 25% vecuronium respectively. Conclusions: The presence of anaphylactic reactions was observed with the use of neuromuscular blockers, which occurred in a short period at the beginning of induction. The atracurium presented the highest frequency and all were of mild intensity.


REFERENCES

  1. Heir PH, Clarke RC, Bunning DL, Platt PR. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. Br J Anaesth. 2013;110:981-987.

  2. Reddy JI, Cooke PJ, Van Schalkwyk JM, Hannam JA, Fitzharris P, Mitchell SJ. Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium. Anesthesiology 2015;122:39-45.

  3. Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol. 2009;123:434-442.

  4. Mertes PM, Malinovsky JM, Jouffroy L, Sfa, Aberer W. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol. 2011;21:442-453.

  5. Dong SW, Mertes PM, Petitpain N, Hasdenteufel F, Malinovsky JM. GERAP. Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005-2007). Minerva Anestesiol 2012;78:868-878.

  6. Mertes PM, Volcheck GW. Anaphylaxis to neuromuscular-blocking drugs: all neuromuscular-blocking drugs are not the same. Anesthesiology. 2015;122:5-7.

  7. Mertes PM, Tajima K, Regnier-Kimmoun MA, Lambert M, Iohom G, Gueant-Rodriguez RM, et al. Perioperative anaphylaxis. Med Clin NA. 2010;94:761-789.

  8. Galvao VR, Giavina-Bianchi P, Castells M. Perioperative anaphylaxis. Curr Allergy Asthma Rep. 2014;14:452.

  9. Volcheck GW, Mertes PM. Local and general anesthetics immediate hypersensitivity reactions. Immunol Allergy Clin NA. 2014;34:525-546.

  10. Dewachter P, Mouton-Faivre C, Emala CW. Anaphylaxis and anesthesia: controversies and new insights. Anesthesiology. 2009;111:1141-1150.

  11. Escolano VF, Sánchez NS. Anafilaxia en anestesia. Rev Esp Anestesiol Rean. 2013;60:55-64.

  12. Harper NJ, Dixon T, Dugue P, Edgar DM, Fay A, Gooi HC. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia. 2009;64:199-211.

  13. Kawano T, Tamura T, Hamaguchi M, Yatabe T, Yamashita K, Yokoyama M. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report. J Clin Anesth. 2012;24:62-64.

  14. Barthel F, Stojeba N, Lyons G, Biermann C, Diemunsch P. Sugammadex in rocuronium anaphylaxis: dose matters. Br J Anaesth. 2012;109:646-647.

  15. Pani N, Dongare PA, Mishra RK. Reversal agents in anaesthesia and critical care. Indian J Anaesth. 2015;59:664-669.

  16. Kageyama K, Hayakawa Y, Nakajima Y, Hashimoto S. Anaphylaxis during anesthesia--especially from neuromuscular blocking agents. Masui. 2011;60:55-66.

  17. Hagau N, Gherman N, Cocis M, Petrisor C. Antibiotic-induced immediate type hypersensitivity is a risk factor for positive allergy skin tests for neuromuscular blocking agents. Allergol Int. 2016;65:52-55.

  18. Rouzaire P, Nosbaum A, Mullet C, Diot N, Dubost R, Bienvenu F et al. Immediate allergic hypersensitivity to quinolones associates with neuromuscular blocking agent sensitization. J Allergy Clin Immunol Pract. 2013;1:273-279.

  19. Brusch AM, Clarke RC, Platt PR, Phillips EJ. Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis. Br J Clin Pharmacol. 2014;78:14-23.

  20. Michavila GA, Belver GM, Alvarez NC, Giner MM, Hernando SV, Porto AJ, et al. Drug allergy Work Group of the Spanish Society of Paediatric Allergy, Immunology (GEICAP). Perioperative anaphylactic reactions: Review and procedure protocol in paediatrics. Allergol Immunopathol (Madr). 2015;43:203-214.

  21. Dong S, Acouetey DS, Guéant-Rodriguez RM, Zmirou-Navier D, Rémen T, Blanca M, et al. Prevalence of IgE against neuromuscular blocking agents in hairdressers and bakers. Clin Exp Allergy. 2013;43:1256-1262.

  22. Michalska-Krzanowska G. Anaphylactic reactions during anaesthesia and the perioperative period. Anaesthesiol Intensive Ther. 2012;44:104-111.

  23. Mertes PM, De Blay F, Dong S. Allergic risk in anaesthesia. Presse Med. 2013;42:269-79.

  24. Mertes PM, Demoly P, Malinovsky JM. Hypersensitivity reactions in the anesthesia setting/allergic reactions to anesthetics. Curr Opin Allergy Clin Immunol. 2012;12:361-368.

  25. Blichfeldt L, Garvey LH, Krøigaard M, Mosbech H. Suspected allergic reaction during anesthesia requires thorough postoperative investigation. Ugeskr Laeger. 2012;174:579-580.

  26. Ramirez LF, Pereira A, Chiriac AM, Bonnet-Boyer MC, Demoly P. Negative predictive value of skin tests to neuromuscular blocking agents. Allergy. 2012;67:439-441.

  27. Jones PM, Turkstra TP. Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown. Anaesthesia. 2010;65:89-90.

  28. Baldo BA, McDonnell NJ, Pham NH. The cyclodextrin sugammadex and anaphylaxis to rocuronium: is rocuronium still potentially allergenic in the inclusion complex form? Mini Rev Med Chem. 2012;12:701-712.

  29. Platt PR, Clarke RC, Johnson GH, Sadleir PH. Efficacy of sugammadex in rocuronium-induced or antibiotic-induced anaphylaxis. A case-control study. Anaesthesia. 2015;70:1264-1267.

  30. Takazawa T, Tomita Y, Yoshida N, Tomioka A, Horiuchi T, Nagata C, et al. Three suspected cases of sugammadex-induced anaphylactic shock. BMC Anesthesiol. 2014;14:92.

  31. McDonnell NJ, Pavy TJ, Green LK, Platt PR. Sugammadex in the management of rocuronium-induced anaphylaxis. Br J Anaesth. 2011;106:199-201.

  32. Clarke RC, Sadleir PH, Platt PR. The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model. Anaesthesia. 2012;67:266-273.

  33. Tsur A, Kalansky A. Hypersensitivity associated with sugammadex administration: a systematic review. Anaesthesia. 2014;69:1251-1257.

  34. Baldo BA, McDonnell NJ. Sugammadex and anaphylaxis in the operating theater. Rev Esp Anestesiol Reanim. 2014;61:239-245.

  35. Takazawa T, Itsuhata H, Mertes PM. Sugammadex and rocuronium-induced anaphylaxis. J Anesth. 2015;8:1-8.




2020     |     www.medigraphic.com